Navigating Secondary Acute Myeloid Leukemias

This chapter explores secondary acute myeloid leukemias (AML) arising from prior hematologic conditions or treatments, emphasizing the complexities of diagnosing and treating older patients. It highlights advancements in therapeutic approaches, particularly the combination of azacitidine and venetoclax, and the shift towards individualized treatment plans. The discussion also addresses the evolving understanding of prognosis in secondary AML, emphasizing the potential for long-term survivorship with proper management.